Visium Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Visium Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000,000	Closed	-$10.6M	–	1337
2015 Q2	$10.6M	Sell	1,000,000 -898,000	-47%	-$10.5M	0.15%	147
2015 Q1	$23.5M	Sell	1,898,000 -1,512,000	-44%	-$16.7M	0.35%	56
2014 Q4	$31.8M	Hold	3,410,000	–	–	0.45%	39
2014 Q3	$34.2M	Hold	3,410,000	–	–	0.5%	32
2014 Q2	$35.2M	Hold	3,410,000	–	–	0.55%	29
2014 Q1	$42.5M	Buy	3,410,000 +5,000	+0.1%	+$59.2K	0.69%	21
2013 Q4	$41.9M	Hold	3,405,000	–	–	0.82%	20
2013 Q3	$29.4M	Buy	3,405,000 +65,000	+2%	+$561K	0.67%	30
2013 Q2	$29.1M	Buy	+3,340,000	New	+$29.9M	0.68%	34

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Visium Asset Management's ELOS Position: Q3 2015 in Review

Visium Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2015, closing a stake of 1,000,000 shares — an estimated $10.6M sold.

Visium Asset Management first reported a position in ELOS in Q2 2013 and held it in 9 quarters. The position peaked at $42.5M in Q1 2014. 66 funds tracked by Wall St. Rank hold ELOS as of Q3 2015.

Visium Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 1,000,000 Syneron Medical Ltd shares in Q3 2015, an estimated $10.6M.
Visium Asset Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 9 quarters.
Visium Asset Management's Syneron Medical Ltd position peaked at $42.5M in Q1 2014.
66 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.